Noven Pharmaceuticals, Inc. is recalling 132,830 boxes of Minivelle (estradiol transdermal system) patches because they may not stick properly to the skin. The patches failed to meet quality specifications for adhesive properties, meaning they may peel off or fail to stay in place during use. Affected products include the 0.1 mg/day and 0.0375 mg/day strengths sold in boxes of 8 pouches nationwide.
If the patch does not adhere properly to the skin, the patient may not receive the intended dose of medication. This could lead to a recurrence of symptoms or ineffective treatment of the condition for which the estradiol was prescribed.
Pharmacy refund and healthcare consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.